Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 398

1.

Label-free quantitative proteomic analysis of the YAP/TAZ interactome.

Kohli P, Bartram MP, Habbig S, Pahmeyer C, Lamkemeyer T, Benzing T, Schermer B, Rinschen MM.

Am J Physiol Cell Physiol. 2014 May 1;306(9):C805-18. doi: 10.1152/ajpcell.00339.2013. Epub 2014 Feb 26.

2.

The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.

Santucci M, Vignudelli T, Ferrari S, Mor M, Scalvini L, Bolognesi ML, Uliassi E, Costi MP.

J Med Chem. 2015 Jun 25;58(12):4857-73. doi: 10.1021/jm501615v. Epub 2015 Mar 11. Review.

PMID:
25719868
3.

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D, Guan KL.

Genes Dev. 2015 Jun 15;29(12):1271-84. doi: 10.1101/gad.262816.115.

4.

Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes.

Grannas K, Arngården L, Lönn P, Mazurkiewicz M, Blokzijl A, Zieba A, Söderberg O.

J Mol Biol. 2015 Oct 23;427(21):3407-15. doi: 10.1016/j.jmb.2015.04.015. Epub 2015 May 1.

PMID:
25937570
5.

The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.

Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X.

J Biol Chem. 2014 Jan 24;289(4):1886-91. doi: 10.1074/jbc.C113.529362. Epub 2013 Dec 9.

6.

The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.

Shimomura T, Miyamura N, Hata S, Miura R, Hirayama J, Nishina H.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):917-23. doi: 10.1016/j.bbrc.2013.12.100. Epub 2013 Dec 28.

PMID:
24380865
7.

Metabolic control of YAP and TAZ by the mevalonate pathway.

Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, Rosato A, Piccolo S, Del Sal G.

Nat Cell Biol. 2014 Apr;16(4):357-66. doi: 10.1038/ncb2936. Epub 2014 Mar 23.

PMID:
24658687
8.

The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences.

Hau JC, Erdmann D, Mesrouze Y, Furet P, Fontana P, Zimmermann C, Schmelzle T, Hofmann F, Chène P.

Chembiochem. 2013 Jul 8;14(10):1218-25. doi: 10.1002/cbic.201300163. Epub 2013 Jun 18.

PMID:
23780915
9.

The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.

Hansen CG, Ng YL, Lam WL, Plouffe SW, Guan KL.

Cell Res. 2015 Dec;25(12):1299-313. doi: 10.1038/cr.2015.140. Epub 2015 Nov 27.

10.

WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ.

Chan SW, Lim CJ, Huang C, Chong YF, Gunaratne HJ, Hogue KA, Blackstock WP, Harvey KF, Hong W.

Oncogene. 2011 Feb 3;30(5):600-10. doi: 10.1038/onc.2010.438. Epub 2010 Oct 25.

11.

Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.

Lin KC, Moroishi T, Meng Z, Jeong HS, Plouffe SW, Sekido Y, Han J, Park HW, Guan KL.

Nat Cell Biol. 2017 Jul 28;19(8):996-1002. doi: 10.1038/ncb3581. Erratum in: Nat Cell Biol. 2018 Sep;20(9):1098.

12.

The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.

Plouffe SW, Lin KC, Moore JL 3rd, Tan FE, Ma S, Ye Z, Qiu Y, Ren B, Guan KL.

J Biol Chem. 2018 Jul 13;293(28):11230-11240. doi: 10.1074/jbc.RA118.002715. Epub 2018 May 25.

PMID:
29802201
13.

Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.

Kim M, Kim T, Johnson RL, Lim DS.

Cell Rep. 2015 Apr 14;11(2):270-82. doi: 10.1016/j.celrep.2015.03.015. Epub 2015 Apr 2.

14.

Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.

Rashidian J, Le Scolan E, Ji X, Zhu Q, Mulvihill MM, Nomura D, Luo K.

Sci Signal. 2015 Feb 10;8(363):ra14. doi: 10.1126/scisignal.2005735.

15.

Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.

Nallet-Staub F, Marsaud V, Li L, Gilbert C, Dodier S, Bataille V, Sudol M, Herlyn M, Mauviel A.

J Invest Dermatol. 2014 Jan;134(1):123-132. doi: 10.1038/jid.2013.319. Epub 2013 Jul 29.

16.

YAP and TAZ regulate skin wound healing.

Lee MJ, Byun MR, Furutani-Seiki M, Hong JH, Jung HS.

J Invest Dermatol. 2014 Feb;134(2):518-525. doi: 10.1038/jid.2013.339. Epub 2013 Aug 9.

17.

A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.

Gill MK, Christova T, Zhang YY, Gregorieff A, Zhang L, Narimatsu M, Song S, Xiong S, Couzens AL, Tong J, Krieger JR, Moran MF, Zlotta AR, van der Kwast TH, Gingras AC, Sicheri F, Wrana JL, Attisano L.

Nat Commun. 2018 Aug 29;9(1):3510. doi: 10.1038/s41467-018-05939-2.

18.

Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein.

Zhao B, Kim J, Ye X, Lai ZC, Guan KL.

Cancer Res. 2009 Feb 1;69(3):1089-98. doi: 10.1158/0008-5472.CAN-08-2997. Epub 2009 Jan 13.

19.

Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).

Gandhirajan RK, Jain M, Walla B, Johnsen M, Bartram MP, Huynh Anh M, Rinschen MM, Benzing T, Schermer B.

J Biol Chem. 2016 May 27;291(22):11596-607. doi: 10.1074/jbc.M115.712539. Epub 2016 Apr 5.

20.

YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function.

Tsutsumi R, Masoudi M, Takahashi A, Fujii Y, Hayashi T, Kikuchi I, Satou Y, Taira M, Hatakeyama M.

Dev Cell. 2013 Sep 30;26(6):658-65. doi: 10.1016/j.devcel.2013.08.013. Epub 2013 Sep 12.

Supplemental Content

Support Center